WITHUS PHARMACEUTICAL Co.,LTD.

Research WITHUS PHARMACEUTICAL Co.,LTD. (330350.KQ) on Bullrun: market cap KRW 89.76B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 89.76B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 89.76Bn/an/an/a

About WITHUS PHARMACEUTICAL Co.,LTD.

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

Dongwha Pharm.Co.,Ltd (000020.KS) Yuhan Corporation (000100.KS) Yuyu Pharma, Inc. (000220.KS) Ildong Holdings Co., Ltd. (000230.KS) Samil Pharmaceutical Co.,Ltd (000520.KS) Dong-A Socio Holdings Co., Ltd. (000640.KS) JW Pharmaceutical Corporation (001060.KS) SAMSUNG PHARM. Co., LTD. (001360.KS) Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) Chong Kun Dang Holdings Corp. (001630.KS) Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) HANDOK Inc. (002390.KS)

Frequently asked questions

What is WITHUS PHARMACEUTICAL Co.,LTD.'s market cap?

WITHUS PHARMACEUTICAL Co.,LTD.'s market capitalization is KRW 89.76B.

What does WITHUS PHARMACEUTICAL Co.,LTD. do?

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name to WITHUS PHARMACEUTICAL Co.,LTD. in October 2007.